ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer, a heterogeneous subtype characterized by the absence of estrogen, progesterone, and ERBB2 (formerly HER2) receptor expression, accounts for approximately 15% of all breast cancer cases.2